Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSEAMERICAN:AMS TSE:ARA.TO NASDAQ:BOLT NASDAQ:CME On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAMSAmerican Shared Hospital Services$2.57+3.6%$2.48$2.27▼$4.60$16.58M0.3113,405 shs2,256 shsARA.TOAclara ResourcesC$0.00C$0.00▼C$0.00N/AN/AN/AN/ABOLTBolt Biotherapeutics$5.50-2.3%$5.94$5.20▼$14.36$10.56M0.915,168 shs4,462 shsCMECME Group$275.88-3.5%$275.74$204.16▼$290.79$99.42B0.442.35 million shs2.74 million shsAnalysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAMSAmerican Shared Hospital Services-2.36%-0.40%+0.40%-12.98%-7.46%BOLTBolt Biotherapeutics-0.59%-1.48%-10.55%-19.80%-60.48%CMECME Group+1.25%-0.47%+3.88%+6.49%+38.27%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAMSAmerican Shared Hospital Services1.3244 of 5 stars0.02.00.00.02.41.71.9ARA.TOAclara ResourcesN/AN/AN/AN/AN/AN/AN/AN/ABOLTBolt Biotherapeutics3.0601 of 5 stars3.22.00.00.02.73.31.3CMECME Group4.547 of 5 stars2.05.02.52.93.53.31.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAMSAmerican Shared Hospital Services 0.00N/AN/AN/AARA.TOAclara Resources 0.00N/AN/AN/ABOLTBolt Biotherapeutics 2.33Hold$50.00809.09% UpsideCMECME Group 2.06Hold$261.93-5.06% DownsideCurrent Analyst Ratings BreakdownLatest ARA.TO, AMS, BOLT, and CME Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/24/2025CMECME GroupOppenheimerSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$300.00 ➝ $303.007/24/2025CMECME GroupBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetEqual Weight ➝ Equal Weight$299.00 ➝ $298.007/24/2025CMECME GroupUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Neutral$305.007/15/2025CMECME GroupPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$283.00 ➝ $296.007/10/2025CMECME GroupBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetEqual Weight ➝ Equal Weight$283.00 ➝ $299.007/3/2025CMECME GroupCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$265.00 ➝ $275.006/4/2025CMECME GroupOppenheimerSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$282.00 ➝ $300.005/24/2025CMECME GroupErste Group BankSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold5/20/2025BOLTBolt BiotherapeuticsLake Street CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$80.005/13/2025BOLTBolt BiotherapeuticsStifel NicolausSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetHold ➝ Hold$25.00 ➝ $20.00(Data available from 8/12/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAMSAmerican Shared Hospital Services$28.34M0.58$0.90 per share2.86$4.68 per share0.55ARA.TOAclara ResourcesN/AN/AN/AN/AN/AN/ABOLTBolt Biotherapeutics$7.69M1.37N/AN/A$29.89 per share0.18CMECME Group$6.13B16.22$11.08 per share24.90$73.66 per share3.75Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAMSAmerican Shared Hospital Services$2.19M$0.6011.688.57N/A5.00%-4.20%-2.09%8/13/2025 (Estimated)ARA.TOAclara ResourcesN/AN/A0.00N/AN/AN/AN/AN/AN/ABOLTBolt Biotherapeutics-$63.12M-$33.40N/AN/AN/AN/A-94.51%-59.07%8/12/2025 (Estimated)CMECME Group$3.53B$10.3326.7125.105.0158.48%14.60%2.61%10/22/2025 (Estimated)Latest ARA.TO, AMS, BOLT, and CME EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/13/2025Q2 2025AMSAmerican Shared Hospital Services-$0.07N/AN/AN/A$7.29 millionN/A8/12/2025Q2 2025BOLTBolt Biotherapeutics-$6.40N/AN/AN/A$0.82 millionN/A7/23/2025Q2 2025CMECME Group$2.91$2.96+$0.05$2.81$1.68 billion$1.69 billion5/12/2025Q1 2025BOLTBolt Biotherapeutics-$6.80-$5.80+$1.00-$0.29$0.77 million$1.22 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAMSAmerican Shared Hospital ServicesN/AN/AN/AN/AN/AARA.TOAclara ResourcesN/AN/AN/AN/AN/ABOLTBolt BiotherapeuticsN/AN/AN/AN/AN/ACMECME Group$5.001.81%N/A48.40%N/ALatest ARA.TO, AMS, BOLT, and CME DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date8/7/2025CMECME Groupquarterly$1.251.78%9/9/20259/25/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAMSAmerican Shared Hospital Services0.581.871.87ARA.TOAclara ResourcesN/AN/AN/ABOLTBolt Biotherapeutics0.483.133.13CMECME Group0.121.021.02Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAMSAmerican Shared Hospital Services23.16%ARA.TOAclara ResourcesN/ABOLTBolt Biotherapeutics86.70%CMECME Group87.75%Insider OwnershipCompanyInsider OwnershipAMSAmerican Shared Hospital Services23.80%ARA.TOAclara ResourcesN/ABOLTBolt Biotherapeutics30.90%CMECME Group0.30%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAMSAmerican Shared Hospital Services106.45 million4.92 millionNot OptionableARA.TOAclara Resources46N/AN/ANot OptionableBOLTBolt Biotherapeutics901.92 million1.33 millionNot OptionableCMECME Group3,760360.38 million359.30 millionOptionableARA.TO, AMS, BOLT, and CME HeadlinesRecent News About These CompaniesCME Group Inc. (NASDAQ:CME) Shares Sold by Public Sector Pension Investment BoardAugust 12 at 8:03 AM | marketbeat.comAIA Group Ltd Has $4.42 Million Stock Position in CME Group Inc. (NASDAQ:CME)August 12 at 7:45 AM | marketbeat.comMotley Fool Wealth Management LLC Sells 2,235 Shares of CME Group Inc. (NASDAQ:CME)August 12 at 6:48 AM | marketbeat.com5,181 Shares in CME Group Inc. (NASDAQ:CME) Acquired by Virtu Financial LLCAugust 12 at 5:51 AM | marketbeat.comBitcoin eases from $122,000 high on profit-taking; CPI report loomsAugust 11 at 11:00 PM | coinjournal.netS&P 500 Rebounds As Fallout From Bad Jobs Data Puts Fed Rate Cuts In New FocusAugust 11 at 8:22 AM | seekingalpha.comLockheed Martin Investment Management Co. Increases Stock Position in CME Group Inc. (NASDAQ:CME)August 11 at 5:33 AM | marketbeat.comCME Group Inc. (NASDAQ:CME) Shares Sold by Invesco Ltd.August 11 at 5:12 AM | marketbeat.comZions Bancorporation National Association UT Buys New Holdings in CME Group Inc. (NASDAQ:CME)August 11 at 4:52 AM | marketbeat.comTownsquare Capital LLC Has $6.99 Million Stock Holdings in CME Group Inc. (NASDAQ:CME)August 11 at 4:52 AM | marketbeat.comAtria Wealth Solutions Inc. Raises Stock Holdings in CME Group Inc. (NASDAQ:CME)August 11 at 4:42 AM | marketbeat.comMizuho Securities USA LLC Sells 5,300 Shares of CME Group Inc. (NASDAQ:CME)August 10 at 7:55 AM | marketbeat.comKoa Wealth Management LLC Cuts Stake in CME Group Inc. (NASDAQ:CME)August 10 at 7:00 AM | marketbeat.comFrank Rimerman Advisors LLC Trims Stock Holdings in CME Group Inc. (NASDAQ:CME)August 10 at 6:59 AM | marketbeat.comDonoghue Forlines LLC Makes New $3.83 Million Investment in CME Group Inc. (NASDAQ:CME)August 10 at 6:00 AM | marketbeat.comForsta AP Fonden Sells 13,300 Shares of CME Group Inc. (NASDAQ:CME)August 10 at 5:50 AM | marketbeat.comNational Bank of Canada FI Has $90.21 Million Stake in CME Group Inc. (NASDAQ:CME)August 10 at 5:42 AM | marketbeat.comFederated Hermes Inc. Lowers Position in CME Group Inc. (NASDAQ:CME)August 10 at 3:39 AM | marketbeat.comFed's Bowman makes case for 3 interest rate cuts in 2025 after voting against July holdAugust 9 at 8:37 PM | aol.comAMontana bar shooting suspect taken into custody after weeklong manhunt - ABC NewsAugust 9 at 10:45 AM | news.google.comNMaryland State Retirement & Pension System Sells 2,495 Shares of CME Group Inc. (NASDAQ:CME)August 9 at 6:06 AM | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesWhy the American Eagle Stock Rally Isn't Just Speculation By Gabriel Osorio-Mazilli | July 28, 2025Trump GLP-1 Pilot Program Could Boost Novo Nordisk & Eli LillyBy Jordan Chussler | August 9, 2025Tesla Teams With Samsung—Will Other Chipmakers Follow?By Gabriel Osorio-Mazilli | August 1, 2025Newmont's Financial Strength Sets a High Bar for Gold MinersBy Jeffrey Neal Johnson | August 1, 20253 Natural Gas Stocks Powering the AI Data Center BoomBy Chris Markoch | August 11, 2025ARA.TO, AMS, BOLT, and CME Company DescriptionsAmerican Shared Hospital Services NYSEAMERICAN:AMS$2.57 +0.09 (+3.63%) Closing price 04:10 PM EasternExtended Trading$2.54 -0.02 (-0.97%) As of 05:31 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.American Shared Hospital Services provides stereotactic radiosurgery and advanced radiation therapy equipment. It operates in two segments, Medical Equipment Leasing, and Retail. The company offers radiosurgery equipment for the Gamma Knife stereotactic radiosurgery, a non-invasive procedure to treat malignant and benign brain tumors, and arteriovenous malformations, as well as for trigeminal neuralgia. It also provides financing services for Leksell Gamma Knife units; and leases medical equipment. In addition, the company offers proton beam radiation therapy services in Orlando, Florida and Long Beach, California, as well as offers planning, installation, reimbursement, and marketing support services to its customers. The company markets its solutions to cancer treatment centers, hospitals, and cancer networks worldwide. American Shared Hospital Services was founded in 1980 and is based in San Francisco, California.Aclara Resources TSE:ARA.TOAclara Resources Inc. was incorporated in 2021 and is based in Santiago, Chile.Bolt Biotherapeutics NASDAQ:BOLT$5.50 -0.13 (-2.31%) Closing price 04:00 PM EasternExtended Trading$5.50 0.00 (0.00%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Bolt Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies for the treatment of cancer. The company's lead product candidate BDC-1001, which is in clinical development for the treatment of patients with human epidermal growth factor receptor 2- positive solid tumors, including breast, colorectal, endometrial, and gastroesophageal cancer. It is also developing BDC-3042, an agonist antibody targeting Dectin-2 for range of tumors, such as head and neck, non-small cell lung, ovarian, triple-negative breast, and other cancer. The company has collaboration agreements with Toray Industries, Genmab A/S, Innovent Biologics, Inc., Bristol-Myers Squibb, and F. Hoffmann-La Roche Ltd; and license agreement with Stanford University. The company was formerly known as Bolt Therapeutics, Inc. and changed its name to Bolt Biotherapeutics, Inc. in July 2015. Bolt Biotherapeutics, Inc. was incorporated in 2015 and is headquartered in Redwood City, California.CME Group NASDAQ:CME$275.88 -9.87 (-3.45%) Closing price 04:00 PM EasternExtended Trading$275.94 +0.06 (+0.02%) As of 05:28 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services. The company also provides clearing house services, including clearing, settling, and guaranteeing futures and options contracts, and cleared swaps products traded through its exchanges; and trade processing and risk mitigation services. In addition, the company offers a range of market data services, including real-time and historical data services. It serves professional traders, financial institutions, institutional and individual investors, corporations, manufacturers, producers, governments, and central banks. The company was formerly known as Chicago Mercantile Exchange Holdings Inc. and changed its name to CME Group Inc. in July 2007. The company was founded in 1898 and is headquartered in Chicago, Illinois. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas AST SpaceMobile on Track for Explosive Upside Oklo’s Stock Is Set up for a Correction—Buy It When It Bounces Alphabet Reclaims $200 Threshold—Bull Run Reignited? Apple & Trump: $100B Investment, Tariffs News Push Shares Up 13% How Vertiv Is Cashing in on AI's Power Crisis CrowdStrike Faces Valuation Test Before Key Earnings Report AMD Paves Path for Market Share Gains: Stock Rally Has Just Begun Post-Earnings, How Does D-Wave Stack Up Against Quantum Rivals? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.